The global medical device coating market size was estimated at USD 15,079.9 million in 2024 and is projected to reach USD 23,854.6 million by 2030, growing at a CAGR of 7.9% from 2025 to 2030. The increasing global demand for ventilators, catheters, cardiovascular devices, guide wires, sutures, syringes, mandrels, stents, and other devices used in the healthcare field.
Due to rising government expenditures on healthcare facilities post-COVID-19, will drive market growth. In addition, factors such as the rising geriatric population, increasing demand for early disease detection and non-invasive treatments, and growing demand for high-quality healthcare are anticipated to drive the demand for medical device coatings in the coming years. The product is crucial for protecting several types of devices used in the medical sector. These coatings boost the maneuverability and performance of medical devices and also protect them from pathogens and microbial factors. In addition, it offers excellent thermal stability, dielectric properties, and dry-film lubricity. This is expected to provide tremendous market potential over the forecast years. A rise in the frequency of Hospital-acquired Infections (HAIs) is fueling the growth of the market.
For instance, the use of contaminated devices can spread HAIs, requiring medical device coatings to stop the spread of the infection, as these coatings have antimicrobial properties. These coatings are materials that enhance a medical device’s performance & mobility and are used to protect the surfaces of several medical devices, including those used in dentistry, neurology, and other fields. Moreover, it provides excellent thermal stability, dry-film lubricity, and dielectric properties, which are likely to generate significant market potential over the forecast period.
The medical device coatings industry is characterized by a moderately concentrated structure, with a mix of specialized coating companies, raw material suppliers, and large medical device manufacturers participating in the value chain. Key players such as Surmodics, DSM Biomedical, Hydromer Inc., Harland Medical Systems, Covalon Technologies, and Biocoat Inc. lead the market through technological innovation, proprietary coating platforms, and strong partnerships with OEMs. The presence of barrier-to-entry technologies, such as hydrophilic and drug-eluting coatings, further contributes to market consolidation around a few high-tech firms.
This market is driven by performance-critical applications, where coatings enhance biocompatibility, lubricity, antimicrobial resistance, corrosion protection, and drug delivery. Hydrophilic coatings dominate in minimally invasive devices like catheters and guidewires, while antimicrobial and drug-eluting coatings are rapidly gaining prominence in orthopedic implants and cardiovascular devices due to rising hospital-acquired infection (HAI) concerns.
Antimicrobial coatings dominated the product segment in 2024, with the largest revenue share of more than 22.3% of the overall revenue. This is attributed to their lower price and higher compatibility with different device materials, such as composite materials, carbon fiber, metal, stainless steel, and plastic. The segment is predicted to expand because of the growing R&D efforts and increasing implantable device usage. In addition, the prevalence of healthcare infections, such as pneumonia, linked to ventilators and catheter-associated urinary tract infections, is forcing medical device manufacturers to coat their products with antimicrobial agents. Increasing research and development activities and growing awareness regarding HAIs have led to the dominant share of antimicrobial coatings.
For instance, according to a 2018 report from the U.S. Centers for Disease Control and Prevention, approximately 1.7 million hospitalized patients develop Healthcare-associated Infections (HCAIs) annually while receiving treatment for other medical conditions. The need to prevent germs from growing is boosting the demand for antimicrobial coatings. Hydrophilic coatings are likely to grow at the fastest CAGR over the forecast period owing to their wide usage in medical devices, such as pacemakers. The product demand will also be driven by its benefits, such as reduced friction, optical clarity, improved durability & lubricity, and the ability to withstand maintenance procedures, including sterilization, storage, and cleaning. Devices like tubes benefit from hydrophilic surface coatings that improve their wettability, thereby improving their interaction with biological tissues.
In terms of application, the global industry has been further categorized into neurology, orthopedics, general surgery, cardiovascular, dentistry, gynecology, and others segments. The cardiovascular application segment dominated the industry with the maximum revenue share of more than 26.65% in 2024. The high share of the segment can be attributed to the growing popularity of cardiac pacemakers and implants. In addition, the growth is fueled by the rising demand for drug-eluting coatings used for coronary stents. The increasing geriatric population and high consumption of unhealthy diets, coupled with sedentary lifestyles, are likely to increase the occurrence of Cardiovascular Diseases(CVDs).
Moreover, the segment is expected to grow due to favorable government policies, such as reimbursement coverage and an increase in healthcare spending. On the other hand, the neurology segment is estimated to register the fastest CAGR during the forecast period. General surgery application emerged as the second-largest application segment in 2024 and is predicted to witness prominent growth over the forecast years. This is attributed to the growing product usage in a variety of parts, including CPUs, graphics cards, chipsets, and hard disks.
The North America medical device coating industry dominated the global medical device coating market in 2024 and accounted for the largest share of more than 40.94% of the overall revenue. The large share of this region can be attributed to favorable healthcare resources coupled with the increasing frequency of cardiometabolic disorders, including Deep Vein Thrombosis and Pulmonary Embolism. Moreover, the growing healthcare infrastructure and high adoption rate of advanced surgical treatments in the U.S. are predicted to fuel product demand during the forecast years. The region is witnessing increased adoption of antimicrobial, hydrophilic, and drug-eluting coatings in minimally invasive devices due to rising concerns over hospital-acquired infections (HAIs). Regulatory stringency from the U.S. FDA is also fueling innovation in biocompatible and non-toxic coatings, while partnerships between coating technology firms and OEMs are becoming more common to accelerate time-to-market. Additionally, demand for coatings compatible with next-gen robotic surgical systems and wearables is steadily increasing.
The U.S. medical device coatings industry remains the largest and most technologically advanced, driven by a robust healthcare infrastructure, strong R&D spending, and a high concentration of medical device manufacturers, particularly in the U.S.
Asia Pacific medical device coatings industry is anticipated to witness the fastest CAGR over the forecast period, driven by expanding healthcare infrastructure, increasing medical tourism, and government support for domestic medical device manufacturing, particularly in China, India, South Korea, and Japan.
Europe medical device coatings industry is characterized by sustainability, safety compliance, and innovation in advanced materials. The region is strongly regulated under REACH and MDR (Medical Device Regulation), prompting manufacturers to invest in coatings that meet rigorous biocompatibility and performance standards. Countries such as Germany, Switzerland, and the Netherlands are leading hubs for precision medical devices and coatings development. Trends include rising demand for bioresorbable coatings in orthopedic and cardiovascular implants, and antithrombogenic coatings in vascular access devices. There is also a growing interest in plasma surface treatments and nanostructured coatings that enhance device functionality while ensuring regulatory conformity.
The Middle East & Africa medical device coatings industry shows emerging potential in the medical device coatings sector, primarily driven by growing healthcare investments, infrastructure modernization, and government-led diversification programs in countries like Saudi Arabia, UAE, and South Africa.
The medical device coatings industry in Central and South America is growing steadily, albeit from a smaller base, driven by improvements in public and private healthcare systems and rising procedural volumes in countries like Brazil, Mexico, and Colombia.
Some of the key players operating in the market include SurModics Inc., Sono-Tek Corp., DSM, Hydromer, Inc., among others.
Surmodics Inc. is a leading provider of surface modification and drug delivery technologies for medical devices. The company specializes in hydrophilic, antimicrobial, and drug-coated technologies, which enhance the performance and biocompatibility of vascular and interventional devices. Surmodics serves major OEMs across cardiovascular, peripheral, and neurovascular markets by offering customizable coating platforms and end-to-end development services.
Sono-Tek Corporation is a global leader in ultrasonic spray coating systems, serving medical device, electronics, and industrial markets. In the medical field, Sono-Tek's precision coating solutions are used for applying thin, uniform layers of drug-eluting, antimicrobial, and lubricious coatings on stents, catheters, and diagnostic tools.
The following are the leading companies in the medical device coatings market. These companies collectively hold the largest market share and dictate industry trends.
Report Attribute |
Details |
Market size value in 2025 |
USD 16,274.2 million |
Revenue forecast in 2030 |
USD 23.85 billion |
Growth rate |
CAGR of 7.9% from 2025 to 2030 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion, Volume in Kilotons, and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, and region |
Regional scope |
North America; Europe; Asia Pacific; Central & South America; Middle East & Africa |
Country scope |
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; China; India; Japan; South Korea; ASEAN; Brazil; Argentina; Chile; South Africa; UAE |
Key companies profiled |
SurModics Inc.; Sono-Tek Corp.; DSM; Hydromer; Inc.; Covalon Technologies Ltd.; Infinita Biotech Pvt. Ltd., Materion Corp. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global medical device coatings market report based on product, application, and region.
Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Hydrophilic Coatings
Antimicrobial Coatings
Drug-eluting Coatings
Anti-thrombogenic Coatings
Others
Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Neurology
Orthopedics
General surgery
Cardiovascular
Dentistry
Gynecology
Others
Soil
Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
India
Japan
South Korea
Central & South America
Brazil
Argentina
Middle East and Africa
Saudi Arabia
South Africa
b. The global medical device coatings market size was estimated at USD 15.08 billion in 2024 and is expected to reach USD 16.27 billion in 2025.
b. The global medical device coating market is expected to grow at a compound annual growth rate of 7.9% from 2025 to 2030 to reach USD 23.85 billion by 2030.
b. North America dominated the medical device coating market with a share of 40.9% in 2024. This is attributable to rising healthcare awareness coupled with rising frequency of cardiometabolic disorders such as Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) in the region.
b. Some key players operating in the medical device coating market include SurModics Inc., Sono-Tek Corporation, DSM, Hydromer, Inc., Covalon Technologies Ltd., Infinita Biotech Private Limited, Materion Corporation, and others.
b. Key factors that are driving the medical device coating market growth include the increasing demand for catheters, ventilators, catheters, cardiovascular devices, guide wires, sutures, syringes, mandrels, stents, and other devices used in the healthcare field due to rising government expenditures on healthcare facilities post covid globally.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."